Klungel OH - Search Results

1

Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use.

Marees AT, Hammerschlag AR, Bastarache L, de Kluiver H, Vorspan F, van den Brink W, Smit DJ, Denys D, Gamazon ER, Li-Gao R, Breetvelt EJ, de Groot MCH, Galesloot TE, Vermeulen SH, Poppelaars JL, Souverein PC, Keeman R, de Mutsert R, Noordam R, Rosendaal FR, Stringa N, Mook-Kanamori DO, Vaartjes I, Kiemeney LA, den Heijer M, van Schoor NM, Klungel OH, Maitland-Van der Zee AH, Schmidt MK, Polderman TJC, van der Leij AR, Posthuma D, Derks EM. Marees AT, et al. Among authors: klungel oh. Drug Alcohol Depend. 2018 Jul 1;188:94-101. doi: 10.1016/j.drugalcdep.2018.03.026. Epub 2018 Apr 25. Drug Alcohol Depend. 2018. PMID: 29758381 Free article.

2

Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels.

Mantel-Teeuwisse AK, Kloosterman JM, Maitland-van der Zee AH, Klungel OH, Porsius AJ, de Boer A. Mantel-Teeuwisse AK, et al. Among authors: klungel oh. Drug Saf. 2001;24(6):443-56. doi: 10.2165/00002018-200124060-00003. Drug Saf. 2001. PMID: 11368251 Review.

3

The association between antihypertensive drug therapies and plasma lipid levels in the general population.

Maitland-van der Zee AH, Klungel OH, Kloosterman JM, Seidell JC, Leufkens HG, de Boer A. Maitland-van der Zee AH, et al. Among authors: klungel oh. J Hum Hypertens. 2001 Oct;15(10):701-5. doi: 10.1038/sj.jhh.1001197. J Hum Hypertens. 2001. PMID: 11607800 Clinical Trial.

4

Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors.

Maitland-van der Zee AH, Klungel OH, Stricker BH, Monique Verschuren WM, Kastelein JJ, Leufkens HG, de Boer A. Maitland-van der Zee AH, et al. Among authors: klungel oh. Atherosclerosis. 2002 Aug;163(2):213-22. doi: 10.1016/s0021-9150(01)00725-0. Atherosclerosis. 2002. PMID: 12052467 Review.

5

Repeated nitrate prescriptions as a potential marker for angina pectoris. A comparison with medical information from the Rotterdam Study.

Maitland-van der Zee AH, Klungel OH, Stricker BH, van der Kuip DA, Witteman JC, Hofman A, Leufkens HG, de Boer A. Maitland-van der Zee AH, et al. Among authors: klungel oh. Pharm World Sci. 2003 Apr;25(2):70-2. doi: 10.1023/a:1023292830670. Pharm World Sci. 2003. PMID: 12774567

6

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men.

Maitland-van der Zee AH, Klungel OH, Stricker BH, Veenstra DL, Kastelein JJ, Hofman A, Witteman JC, Leufkens HG, van Duijn CM, de Boer A. Maitland-van der Zee AH, et al. Among authors: klungel oh. Pharmacogenetics. 2004 Jan;14(1):53-60. doi: 10.1097/00008571-200401000-00006. Pharmacogenetics. 2004. PMID: 15128051

7

Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.

Gumbs PD, Verschuren WM, Souverein PC, Mantel-Teeuwisse AK, de Wit GA, de Boer A, Klungel OH. Gumbs PD, et al. Among authors: klungel oh. Br J Clin Pharmacol. 2007 Nov;64(5):680-5. doi: 10.1111/j.1365-2125.2007.02958.x. Epub 2007 Sep 13. Br J Clin Pharmacol. 2007. PMID: 17875197 Free PMC article.

8

Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins.

Schalekamp T, Klungel OH, Souverein PC, de Boer A. Schalekamp T, et al. Among authors: klungel oh. Arch Intern Med. 2008 Jan 28;168(2):180-5. doi: 10.1001/archinternmed.2007.32. Arch Intern Med. 2008. PMID: 18227365 Clinical Trial.

9

Effect of oral antiplatelet agents on major bleeding in users of coumarins.

Schalekamp T, Klungel OH, Souverein PC, de Boer A. Schalekamp T, et al. Among authors: klungel oh. Thromb Haemost. 2008 Dec;100(6):1076-83. doi: 10.1160/th08-05-0290. Thromb Haemost. 2008. PMID: 19132233

10

Genetic polymorphisms related to the renin-angiotensin-aldosterone system and response to antihypertensive drugs.

Taverne K, de Groot M, de Boer A, Klungel O. Taverne K, et al. Expert Opin Drug Metab Toxicol. 2010 Apr;6(4):439-60. doi: 10.1517/17425250903571670. Expert Opin Drug Metab Toxicol. 2010. PMID: 20102285 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page